Search research articles
Contact Us
Filters
Showing results (391-400 of 692) with videos related to
Page
of 70
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 5, 2018
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
D Planchard, S Popat, K Kerr, et al.
Lung Cancer (Amsterdam, Netherlands)
|
April 9, 2021
Identifying advanced stage NSCLC patients who benefit from afatinib therapy using <sup>18</sup>F-afatinib PET/CT imaging
Eveline A van de Stadt, Maqsood Yaqub, Adriaan A Lammertsma, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 28, 2014
Assessment of simplified methods to measure 18F-FLT uptake changes in EGFR-mutated non-small cell lung cancer patients undergoing EGFR tyrosine kinase inhibitor treatment
Virginie Frings, Maqsood Yaqub, Lieke L Hoyng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 1, 2024
Combining Genomic Biomarkers to Guide Immunotherapy in Non-Small Cell Lung Cancer
Joris van de Haar, Joanne M Mankor, Karlijn Hummelink, et al.
European Journal of Radiology
|
October 23, 2024
PSMA PET/CT for treatment response evaluation at predefined time points is superior to PSA response for predicting survival in metastatic castration-resistant prostate cancer patients
F Kleiburg, L F de Geus-Oei, S A C Luelmo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 30, 2013
A randomized phase II study comparing erlotinib versus erlotinib with alternating chemotherapy in relapsed non-small-cell lung cancer patients: the NVALT-10 study
J G Aerts, H Codrington, N A G Lankheet, et al.
Plos One
|
May 30, 2013
Pemetrexed induced thymidylate synthase inhibition in non-small cell lung cancer patients: a pilot study with 3'-deoxy-3'-[¹⁸F]fluorothymidine positron emission tomography
Virginie Frings, Astrid A M van der Veldt, Ronald Boellaard, et al.
Acta Oncologica (Stockholm, Sweden)
|
August 21, 2013
Changes in non-surgical management of stage III non-small cell lung cancer at a single institution between 2003 and 2010
Ellen J F van Reij, Max Dahele, Peter M van de Ven, et al.
International Journal of Molecular Sciences
|
January 8, 2023
Detection of Circulating Tumor Cells Using the Attune NxT
Mandy Gruijs, Carolien Zeelen, Tessa Hellingman, et al.
Immuno-Oncology Technology
|
August 15, 2022
Effective generation of tumor-infiltrating lymphocyte products from metastatic non-small-cell lung cancer (NSCLC) lesions irrespective of location and previous treatments
S M Castenmiller, R de Groot, A Guislain, et al.
Page
of 70
Search research articles
Search
Showing results (391-400 of 692) with videos related to
Sort By:
Page
of 70
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 5, 2018
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
D Planchard, S Popat, K Kerr, et al.
Lung Cancer (Amsterdam, Netherlands)
|
April 9, 2021
Identifying advanced stage NSCLC patients who benefit from afatinib therapy using <sup>18</sup>F-afatinib PET/CT imaging
Eveline A van de Stadt, Maqsood Yaqub, Adriaan A Lammertsma, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 28, 2014
Assessment of simplified methods to measure 18F-FLT uptake changes in EGFR-mutated non-small cell lung cancer patients undergoing EGFR tyrosine kinase inhibitor treatment
Virginie Frings, Maqsood Yaqub, Lieke L Hoyng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 1, 2024
Combining Genomic Biomarkers to Guide Immunotherapy in Non-Small Cell Lung Cancer
Joris van de Haar, Joanne M Mankor, Karlijn Hummelink, et al.
European Journal of Radiology
|
October 23, 2024
PSMA PET/CT for treatment response evaluation at predefined time points is superior to PSA response for predicting survival in metastatic castration-resistant prostate cancer patients
F Kleiburg, L F de Geus-Oei, S A C Luelmo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 30, 2013
A randomized phase II study comparing erlotinib versus erlotinib with alternating chemotherapy in relapsed non-small-cell lung cancer patients: the NVALT-10 study
J G Aerts, H Codrington, N A G Lankheet, et al.
Plos One
|
May 30, 2013
Pemetrexed induced thymidylate synthase inhibition in non-small cell lung cancer patients: a pilot study with 3'-deoxy-3'-[¹⁸F]fluorothymidine positron emission tomography
Virginie Frings, Astrid A M van der Veldt, Ronald Boellaard, et al.
Acta Oncologica (Stockholm, Sweden)
|
August 21, 2013
Changes in non-surgical management of stage III non-small cell lung cancer at a single institution between 2003 and 2010
Ellen J F van Reij, Max Dahele, Peter M van de Ven, et al.
International Journal of Molecular Sciences
|
January 8, 2023
Detection of Circulating Tumor Cells Using the Attune NxT
Mandy Gruijs, Carolien Zeelen, Tessa Hellingman, et al.
Immuno-Oncology Technology
|
August 15, 2022
Effective generation of tumor-infiltrating lymphocyte products from metastatic non-small-cell lung cancer (NSCLC) lesions irrespective of location and previous treatments
S M Castenmiller, R de Groot, A Guislain, et al.
Page
of 70